Evaluation study of TIGR® Matrix surgical mesh in Immediate Breast Reconstruction notes excellent outcomes and minimal complications
Press Releases • Nov 25, 2016 12:00 UTC
In an Irish study the researchers investigated the use of TIGR® Matrix long term resorbable mesh in 56 patients undergoing immediate breast reconstructions after mastectomy. The authors concluded that TIGR® Matrix was an effective adjunct for use in breast reconstruction, providing excellent cosmetic outcomes with minimal rates of complications.
Press Releases • Apr 12, 2016 13:28 UTC
A new clinical study evaluating the role of TIGR® Matrix in immediate implant-based breast reconstruction has been published ahead of print by the journal Breast Cancer Management.
Blog posts • Jun 01, 2017 15:23 UTC
Novus Scientific is showcasing TIGR® Matrix surgical mesh in the congress, Beauty Through Science in Stockholm
Interim data comparing TIGR® Matrix versus permanent mesh in ventral hernia presented at the European Hernia Society meeting
Press Releases • May 30, 2017 16:10 UTC
Interim results of a randomized clinical multicenter trial evaluating TIGR® Matrix surgical mesh versus permanent large-pore synthetic mesh in ventral hernia repair have been presented.
Blog posts • Apr 27, 2017 13:45 UTC
Novus Scientific will showcase TIGR®Matrix at the 5th International Breast Symposium Düsseldorf, Friday & Saturday 28- 29th of April. We are exited to meet all delegates at the meeting! Please come and visit us at the booth!
Blog posts • Jan 26, 2017 11:00 UTC
IMCAS Annual World Congress is held in Paris during the month of January and welcomes more than 7 000 participants from 85 countries. This year the congress is taking place between 26 January - 29 January at Palais des Congrès , Paris
Blog posts • Jun 08, 2016 07:40 UTC
Novus Scientific main sponsor at Rome Breast Surgery Symposium 2016
About TIGR® Matrix
TIGR® Matrix (www.TIGRmatrix.com) is an innovative resorbable synthetic surgical mesh.
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable implants, that is aimed to help the body to heal it self.
Global HQ, R&D and manufacturing is located in Uppsala, Sweden.
- TIGR® Matrix
- Virdings Allé 2
- SE 754 50 Uppsala
- Our homepage